|
FY2026
12 months to Mar 31, 2026
|
FY2025
12 months to Mar 31, 2025
|
FY2024
12 months to Mar 31, 2024
|
FY2023
12 months to Mar 31, 2023
|
FY2022
12 months to Mar 31, 2022
|
|
|---|---|---|---|---|---|
| Sales | |||||
| Cost of sales | |||||
| Gross profit | |||||
| Operating expenses: | |||||
| Selling, general and administrative expenses | |||||
| Deferred compensation plan expense/(income) | |||||
| Amortization of intangible assets | |||||
| Restructuring and other charges/(income) | |||||
| Income from operations | |||||
| Other income/(expenses): | |||||
| Interest expense, net | |||||
| Other income/(expense) | |||||
| Income before provision for income taxes | |||||
| Income tax expense | |||||
| Net income | |||||
| Other comprehensive income: | |||||
| Net income | |||||
| Foreign currency translation adjustment | |||||
| Other | |||||
| Total comprehensive income | |||||
| Net income per common share: | |||||
| Basic (in dollars per share) | |||||
| Diluted (in dollars per share) | |||||
| Weighted-average shares used in computing net income per common share: | |||||
| Basic (in shares) | |||||
| Diluted (in shares) | |||||
Loading...